一种体外扩增NK细胞的新方法
A Novel Method for Expanding NK Cells in Vitro
DOI: 10.12677/ACM.2022.12101310, PDF,    科研立项经费支持
作者: 于明晓:济宁医学院,山东 济宁;济宁医学院附属医院儿科血液科,山东 济宁;胡田田, 陶艳玲*:济宁医学院附属医院儿科血液科,山东 济宁;张 颢*:济宁医学院附属医院血液科,山东 济宁
关键词: NK细胞单个核细胞扩增杀伤活性NK Cells Mononuclear Cells Amplification Killing Activity
摘要: 目的:验证一种新型、尚未报道的体外扩增原代NK细胞的方法,同时检测其杀伤活性。方法:采集6位健康志愿者的静脉血共6份,分离外周血单个核细胞。自然杀伤(NK)细胞诱导培养试剂培养14天。利用流式细胞术检测NK细胞所占比例,将K562、THP-1细胞作为靶细胞并用CFSE标记,以效靶比2:1加入扩增后的NK细胞,利用流式细胞术检测靶细胞凋亡。结果:通过14天的细胞培养,利用自然杀伤(NK)细胞诱导培养试剂培养的NK细胞扩增约300倍。NK细胞纯度达50%左右。体外杀伤实验结果显示,扩增后的NK细胞与靶细胞共培养4 h杀伤能力可达40%以上。结论:此种方法扩增的NK细胞其纯度较高,但是因为缺乏其余免疫细胞提供的支撑作用,所以最终NK细胞的扩增倍数并不理想,但其操作简单,花费低,安全性高,可靠性强。
Abstract: Objective: To verify to expand human NK cells ex vivo by using a novel and unreported method and to detect its killing activity. Methods: Mononuclear cells were isolated from 6 samples of peripheral blood from six healthy donors. Natural killer cell induction culture kit was used to culture NK cells from each sample separately for 14 days. The proportion of NK cells was detected by flow cytometry. The K562 and THP-1 cells were used as the targeting cells and the expanded NK cells were added at an effect target ratio of 2:1, and the apoptosis of AML cells was detected by flow cytometry. Results: After 14 days of cell culture, the number of NK cells obtained by natural killer cell induction culture kit for NK cells expanded by 300 times and the ratio of NK cells was about 50.00%. The results of cytotoxicity experiment in vitro showed that the killing ability of NK cells cultured could reach more than 40% when co-cultured with target cells for 4 h. Conclusion: New NK cell culture method using natural killer cell induction culture kit can expand NK cells efficiently and the operation is simple, low cost, high safety and reliability.
文章引用:于明晓, 胡田田, 张颢, 陶艳玲. 一种体外扩增NK细胞的新方法[J]. 临床医学进展, 2022, 12(10): 9059-9064. https://doi.org/10.12677/ACM.2022.12101310

参考文献

[1] Shimasaki, N., Jain, A. and Campana, D. (2020) NK Cells for Cancer Immunotherapy. Nature Reviews Drug Discovery, 19, 200-218. [Google Scholar] [CrossRef] [PubMed]
[2] Terme, M., Ullrich, E., Delahaye, N.F., et al. (2008) Natural Killer Cell-Directed Therapies: Moving from Unexpected Results to Successful Strategies. Nature Immunology, 9, 486-494. [Google Scholar] [CrossRef] [PubMed]
[3] Blunt, M.D. and Khakoo, S.I. (2020) Activating Killer Cell Immunoglobulin-Like Receptors: Detection, Function and Therapeutic Use. International Journal of Immunogenetics, 47, 1-12. [Google Scholar] [CrossRef] [PubMed]
[4] Becker-Hapak, M.K., Shrestha, N., McClain, E., Dee, M.J., Chaturvedi, P., Leclerc, G.M., et al. (2021) A Fusion Protein Complex That Combines IL12, IL15, and IL18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy. Cancer Immunology Research, 9, 1071-1087. [Google Scholar] [CrossRef
[5] Carlsten, M. and Järås, M. (2019) Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells. Frontiers in Immunology, 10, 2357. [Google Scholar] [CrossRef] [PubMed]
[6] Fujisaki, H., Kakuda, H., Shimasaki, N., et al. (2009) Expansion of Highly Cy-totoxic Human Natural Killer Cells for Cancer Cell Therapy. Cancer Research, 69, 4010-4017. [Google Scholar] [CrossRef
[7] Raimondo, S., Corrado, C., Raimondi, L., et al. (2015) Role of Exlracel-lular Vesicles in Hematological Malignancies. BioMed Research International, 2015, Article ID: 821613. [Google Scholar] [CrossRef] [PubMed]
[8] Romee, R., Leong, J.W. and Fehniger, T.A. (2014) Utilizing Cytokines to Func-tion-Enable Human NK Cells for the Immunotherapy of Cancer. Scientifica, 2014, Article ID: 205796. [Google Scholar] [CrossRef] [PubMed]
[9] Hodgins, J.J., Khan, S.T., Park, M.M., et al. (2019) Killers 2.0: NK Cell Therapies at the Forefront of Cancer Control. The Journal of Clinical Investigation, 129, 3499-3510. [Google Scholar] [CrossRef
[10] Hideshima, T., Ogiya, D., Liu, J., et al. (2021) Immunomodulatory Drugs Activate NK Cells via Both Zap-70 and Cereblon-Dependent Pathways. Leukemia, 35, 177-188. [Google Scholar] [CrossRef] [PubMed]